SPINLOCK LIMITED

Financial Health Score: B+

Explanation: Spinlock Limited is a robust and historically resilient patient experiencing a period of rapid growth. However, this expansion is placing significant strain on its circulatory system (cash flow). While the underlying muscle (revenue and equity) is strong, the dramatic drop in cash reserves and the doubling of liabilities present acute symptoms of "overtrading" that require careful management to avoid financial dehydration.

1. Key Vital Signs

• Heart Rate (Revenue Growth): Accelerating. Turnover surged by 27.3% in 2022 to £11.08 million, following a 29.2% increase in 2021. This indicates a strong, beating heart with robust market demand for its products.
• Blood Oxygen (Profit Margins): Mildly Constricted. Pre-tax profit as a percentage of turnover has slightly narrowed, dropping from 11.5% in 2021 to 9.5% in 2022. While the business remains profitable, this indicates that operating costs and inflation are rising slightly faster than revenue, putting mild pressure on the company's breathing room.
• Hydration Levels (Cash Reserves): Dangerously Low. Cash on hand plummeted by 62%, falling from £750,340 in 2021 to just £284,968 in 2022. Despite generating higher sales, the business is severely dehydrated in terms of liquid assets.
• Blood Pressure (Total Liabilities): Spiking. Total liabilities nearly doubled, jumping from £2.61 million to £5.17 million. This is a significant spike that requires immediate investigation to determine if it is healthy debt (investing in the future) or toxic debt (struggling to pay bills).
• Bone Density (Net Assets/Equity): Strengthening. Shareholders' funds grew healthily from £3.26 million to £3.81 million. The core structural integrity of the business is solid, and the business is not eating into its retained earnings to survive.

2. Diagnosis

The patient is suffering from a classic case of Overtrading Syndrome, a condition where a business expands its operations so rapidly that its working capital can no longer support the day-to-day cash requirements.

The primary symptom is the severe cash drain. Despite generating an additional £2.37 million in revenue, the company's cash reserves dried up significantly. This cash has been absorbed by the business's expanding working capital—likely tied up in inventory to meet demand and trade debtors taking longer to pay—as well as a £400,000 dividend payout to its parent company, Spinlock Holdings Limited.

However, there is a silver lining in the liability spike. The strategic report notes that the company acquired a freehold property for its new HQ, which it plans to occupy in August 2023. It is highly probable that a large portion of the increased liabilities is mortgage financing for this property. If so, this is "good cholesterol"—long-term debt secured against a tangible asset that will reduce future lease liabilities.

The slight contraction in profit margins is a mild symptom of the current macroeconomic environment, likely reflecting global supply chain costs and inflation, but it is currently manageable given the company's strong market position and B-Corp certification, which speaks to a sustainable, well-managed operation.

3. Recommendations

To stabilise the patient and ensure long-term wellness, the following treatments are prescribed:

• Cash Flow Therapy (Working Capital Management): The business must aggressively manage its inventory and debtor books. Consider offering early payment discounts to customers to accelerate cash collection. With just £284k in cash on a £11m turnover, a sudden shock could cause a financial cardiac arrest.
• Liability Review (Cholesterol Screening): Management must ensure that the spiked liabilities are indeed weighted toward long-term property debt rather than short-term trade creditor stress. Stretching supplier payments to fund property purchases is a dangerous game that could damage vital supplier relationships.
• Dividend Restraint: Paying out £400,000 in dividends during a year when cash reserves dropped by nearly half a million pounds is aggressive. The business should temporarily suspend or reduce dividend payments to its parent company until cash reserves are restored to healthy levels.
• Margin Protection: Investigate the 2% drop in profit margins. If this is driven by input costs rather than strategic pricing to gain market share, the business may need to implement price increases or renegotiate supplier terms to protect its bottom line.